News Focus
News Focus
Followers 65
Posts 10174
Boards Moderated 0
Alias Born 03/29/2015

Re: learningcurve2020 post# 85263

Sunday, 11/27/2016 4:47:33 PM

Sunday, November 27, 2016 4:47:33 PM

Post# of 817973
I think the markets have priced in bankruptcy and failure of the trial as the cause. If it succeeds it is pivotal. If it fails well it fails.

Now if you want to trot out the old argument that FDA will not accept progression-free survival as a valid endpoint then please do so explicitly and provide proof.

But while the market might just be aware that NWBO even exists enough to believe that it will go under I doubt most investors who trade NWBO are concerned with arcane arguments about progression-free vs overall survival.

That said, I think that the market is correct to price NWBO as a penny stock until we prove otherwise.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News